H.C. Wainwright Downgrades Theravance Biopharma (TBPH) to Neutral

July 7, 2026 7:37 AM

H.C. Wainwright analyst Douglas Tsao downgraded Theravance Biopharma (NASDAQ ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found